URGN (UroGen Pharma Ltd.) operates in the Health technology sector. It's currently trading at $37.75. Our composite momentum score rates it 55/110 based on price +2.7% (1d), rsi 71.0 — overbought, roc9 +18.9% — sharp acceleration, macd 1.23 — strong bullish crossover, beta 1.41 — above-market volatility, and analyst: strong buy. Up 15.1% across 3 tracked price points, from Jul 7, 2026 to Jul 8, 2026.